Ability of azlocillin and tobramycin in combination to delay or prevent resistance development in Pseudomonas aeruginosa

The ability of combinations of azlocillin and tobramycin to prevent or delay resistance development in eight Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients was studied using chequerboard titration and in-vitro serial subculture. No isolate had developed resistance to tobramycin a...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy Vol. 44; no. 3; pp. 389 - 392
Main Authors: YA LI WU, SCOTT, E. M, LI WAN PO, A, TARIQ, V. N
Format: Journal Article
Language:English
Published: Oxford Oxford University Press 01-09-1999
Oxford Publishing Limited (England)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The ability of combinations of azlocillin and tobramycin to prevent or delay resistance development in eight Pseudomonas aeruginosa isolates from cystic fibrosis (CF) patients was studied using chequerboard titration and in-vitro serial subculture. No isolate had developed resistance to tobramycin after 12 treatments with the antibiotic combination. Azlocillin resistance had not developed in four isolates after 16 exposures, and was delayed in the other four isolates for at least eight exposures. Beta-lactamase production was responsible for azlocillin resistance in two isolates and occurred to a lesser extent in a third.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0305-7453
1460-2091
DOI:10.1093/jac/44.3.389